Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: former_pgs who wrote (559)	3/7/2005 5:28:50 PM
From: zeta1961	Read Replies (2) of 946

<If it was up to me I'd let the clinics decide the cost / benefit trade-off that is appropriate.>> They already do..a cursory look at recent actual sales of onc products an example..MOGN last I heard has been constantly revising Aloxi figures based on uptake that the analysts who make these projections could not predict..or could have if they'd spoken to people in the trenches<g> <<However, for CTIC the stock, the plight of patients is not always sufficient to get the various agencies moving in the ways that we would like them to.>> Lost you there..but I think I get your overall point..my point is that alopecia is a side effect that is underappreciated as an issue and imo, would be a deal breaker even if everything else was equal..herds who make a living playing good and bad PR's could care less today..but those who have to make treatment option decisions are looking at these results from a different perspective The ASCO meetings should provide more insight about all this.. Zeta

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next